Colorectal cancer is the third most commonly diagnosed cancer worldwide and the second leading cause of cancer death, yet one ...

Preclinical data demonstrate enhanced efficacy of PLT012 in pMMR colorectal cancer models - Findings position CD36 as a promising metabolic checkpoint target in an underserved patient population DOVER ...

Accent Therapeutics, a clinical-stage biopharmaceutical company pioneering novel small molecule precision cancer therapies, ...

More than three-quarters of all cases of liver cancer worldwide are associated with chronic viral hepatitis but scientists ...

Researchers at The University of Texas MD Anderson Cancer Center have discovered a new blood-based biomarker that can help ...

The findings revealed a shocking truth: High-fat diets are linked to aggressive breast cancer. More importantly, high-fat ...

More than 35,000 men in the United States die from prostate cancer each year. Now, a new study reveals the immune cell ...

Preclinical research has shown that CAR T cells directed against the urokinase plasminogen activator receptor can attack both ...

A new risk stratification tool for skin cancer in solid organ transplant recipients is gaining global validation. Read more.